AVAH - Company ID 0001832332
The table below shows Aveanna Healthcare Holdings, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $647.91M | $621.94M | $589.55M | $559.22M | $509.02M | $504.96M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | $205.43M | $202.82M | $210.80M | $183.56M | $159.70M | $158.27M |
| R&D | - | - | - | - | - | - |
Aveanna Healthcare Holdings, Inc. reported annual revenue of $2.43B for fiscal year 2026. That is up 20.2% from $2.02B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $1.38B (FY 2019) to $2.43B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $95.79M |
| $95.40M |
| $90.07M |
| $91.39M |
| $88.18M |
| $87.97M |
| Operating income | $69.33M | $53.58M | $80.03M | $51.80M | $34.02M | $37.13M |
| Income tax | $3.32M | -$647.00K | $17.11M | $4.96M | $15.51M | -$9.93M |
| Net income | $41.65M | $14.06M | $27.02M | $5.19M | -$42.84M | $13.91M |
| EPS (diluted) | $0.19 | $0.06 | $0.13 | $0.03 | -$0.22 | $0.07 |